Price movement over the last 24 hours
Agilent Technologies Inc vs Quantum Computing Inc — how do they compare? Agilent Technologies Inc trades at $129.02 (market cap $37.04B), while Quantum Computing Inc trades at $8.67 (market cap $1.96B). The key difference: Agilent Technologies Inc is far larger — about 18.9× Quantum Computing Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals.
| A | QUBT | |
|---|---|---|
Market Cap | $37.04B | $1.96B |
Sector | Health | Technology |
52-Week High | $157.20 | $24.62 |
52-Week Low | $110.24 | $6.31 |
Enterprise Value | $38.59B | $977.49M |
Dividend Yield | 0.78% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
QUBT trades at $9.37, up 3.54% today, but technical indicators signal a bearish trend with support at $9. The company shows minimal revenue of $682K in 2025 with a net loss of $18.67M, resulting in negative margins. Recent acquisitions and a potential $10M deal with Planck Dynamics highlight growth efforts, but cash burn remains high. Analyst consensus is bullish with a $24 price target, citing commercialization potential in quantum photonics.
The outlook hinges on QUBT's ability to scale revenue and manage cash burn amid intense quantum computing competition. While analyst optimism and policy tailwinds offer upside, high valuation multiples and persistent losses pose significant risks. Investors should weigh the long-term potential against near-term financial instability.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →